Sleep disorder specialist Centessa is heading for an acquisition by Eli Lilly, which has offered $6.3bn for the US and UK-based biotech.
Merck is tasking a 10-person biotech to hunt for new human antibody candidates. The drug giant will ship up to $838 million to the startup,
You can now pay for Wegovy shots and pills just like you pay for an Amazon Prime subscription. Novo Nordisk said patients paying cash can
The EU has approved UCB’s Kygevi for rare disease TK2d, and Sanofi’s acute GvHD therapy Rezurock, in a pair of decisions announced this morning.
Biogen has made a $5.6 billion deal to acquire Apellis Pharmaceuticals, the companies announced Tuesday. The deal will allow Biogen to get hold of the
Enveda Biosciences’ first-ever clinical readout places its lead eczema drug among the top candidates in an increasingly crowded race to follow the blockbuster immunology treatment Dupixent.
The trial was a Phase 1b test that looked …
Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844